Literature DB >> 23248260

Balance between NF-κB p100 and p52 regulates T cell costimulation dependence.

Maria Letizia Giardino Torchia1, Dietrich B Conze, Dragana Jankovic, Jonathan D Ashwell.   

Abstract

c-IAP1 and c-IAP2 are ubiquitin protein ligases (E3s) that repress noncanonical NF-κB activation. We have created mice that bear a mutation in c-IAP2 that inactivates its E3 activity and interferes, in a dominant-negative fashion, with c-IAP1 E3 activity (c-IAP2(H570A)). The immune response of these animals was explored by infecting them with the Th1-inducing parasite Toxoplasma gondii. Surprisingly, c-IAP2(H570A) mice succumbed because of T cell production of high levels of proinflammatory cytokines. Unlike naive wild-type (WT) cells, which require signals generated by the TCR and costimulatory receptors to become fully activated, naive c-IAP2(H570A) T cells proliferated and produced high levels of IL-2 and IFN-γ to stimulation via TCR alone. c-IAP2(H570A) T cells had constitutive noncanonical NF-κB activation, and IκB kinase inhibition reduced their proliferation to anti-TCR alone to WT levels but had no effect when costimulation via CD28 was provided. Notably, T cells from nfkb2(-/-) mice, which cannot generate the p52 component of noncanonical NF-κB, were also costimulation independent, consistent with the negative role of this unprocessed protein in canonical NF-κB activation. Whereas T cells from nfkb2(+/-) mice behaved like WT, coexpression of a single copy of c-IAP2(H570A) resulted in cleavage of p100, upregulation of p52, and T cell costimulation independence. Thus, p100 represses and p52 promotes costimulation, and the ratio regulates T cell dependence on costimulatory signals.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23248260      PMCID: PMC3538904          DOI: 10.4049/jimmunol.1201697

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

Review 1.  T cell anergy and costimulation.

Authors:  Leonard J Appleman; Vassiliki A Boussiotis
Journal:  Immunol Rev       Date:  2003-04       Impact factor: 12.988

Review 2.  T cell anergy.

Authors:  Ronald H Schwartz
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

3.  High expression of active CDK6 in the cytoplasm of CD8 memory cells favors rapid division.

Authors:  Henrique Veiga-Fernandes; Benedita Rocha
Journal:  Nat Immunol       Date:  2003-11-30       Impact factor: 25.606

4.  Molecular and functional profiling of memory CD8 T cell differentiation.

Authors:  Susan M Kaech; Scott Hemby; Ellen Kersh; Rafi Ahmed
Journal:  Cell       Date:  2002-12-13       Impact factor: 41.582

5.  Tax deregulation of NF-kappaB2 p100 processing involves both beta-TrCP-dependent and -independent mechanisms.

Authors:  Zhaoxia Qu; Guoliang Qing; Arnold Rabson; Gutian Xiao
Journal:  J Biol Chem       Date:  2004-08-13       Impact factor: 5.157

Review 6.  G1 events and regulation of cell proliferation.

Authors:  A B Pardee
Journal:  Science       Date:  1989-11-03       Impact factor: 47.728

7.  The generation of nfkb2 p52: mechanism and efficiency.

Authors:  M Heusch; L Lin; R Geleziunas; W C Greene
Journal:  Oncogene       Date:  1999-11-04       Impact factor: 9.867

8.  Abnormal immune function of hemopoietic cells from alymphoplasia (aly) mice, a natural strain with mutant NF-kappa B-inducing kinase.

Authors:  T Yamada; T Mitani; K Yorita; D Uchida; A Matsushima; K Iwamasa; S Fujita; M Matsumoto
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

Review 9.  T-cell regulation by CD28 and CTLA-4.

Authors:  M L Alegre; K A Frauwirth; C B Thompson
Journal:  Nat Rev Immunol       Date:  2001-12       Impact factor: 53.106

Review 10.  Tumor necrosis factor signaling.

Authors:  H Wajant; K Pfizenmaier; P Scheurich
Journal:  Cell Death Differ       Date:  2003-01       Impact factor: 15.828

View more
  16 in total

Review 1.  Regulation of T cell receptor complex-mediated signaling by ubiquitin and ubiquitin-like modifications.

Authors:  Samantha F Friend; Francina Deason-Towne; Lisa K Peterson; Allison J Berger; Leonard L Dragone
Journal:  Am J Clin Exp Immunol       Date:  2014-12-05

2.  A cell-intrinsic requirement for NF-κB-inducing kinase in CD4 and CD8 T cell memory.

Authors:  Alexander M Rowe; Susan E Murray; Hans-Peter Raué; Yoshinobu Koguchi; Mark K Slifka; David C Parker
Journal:  J Immunol       Date:  2013-09-04       Impact factor: 5.422

3.  IKKα is required for the homeostasis of regulatory T cells and for the expansion of both regulatory and effector CD4 T cells.

Authors:  Xin Chen; Jami Willette-Brown; Xueqiang Wu; Ya Hu; O M Zack Howard; Yinling Hu; Joost J Oppenheim
Journal:  FASEB J       Date:  2014-11-05       Impact factor: 5.191

4.  The Transitional Endoplasmic Reticulum ATPase p97 Regulates the Alternative Nuclear Factor NF-κB Signaling via Partial Degradation of the NF-κB Subunit p100.

Authors:  Zhao Zhang; Yanyan Wang; Chuanchuan Li; Zhubing Shi; Qian Hao; Wenjia Wang; Xiaomin Song; Yun Zhao; Shi Jiao; Zhaocai Zhou
Journal:  J Biol Chem       Date:  2015-06-25       Impact factor: 5.157

5.  c-IAP ubiquitin protein ligase activity is required for 4-1BB signaling and CD8(+) memory T-cell survival.

Authors:  Maria Letizia Giardino Torchia; Ivana Munitic; Ehydel Castro; Jasmin Herz; Dorian B McGavern; Jonathan D Ashwell
Journal:  Eur J Immunol       Date:  2015-07-07       Impact factor: 5.532

6.  Effects of radix curcumae-derived diterpenoid C on Helicobacter pylori-induced inflammation and nuclear factor kappa B signal pathways.

Authors:  Xuan Huang; Bin Lv; Shuo Zhang; Qun Dai; Bing-Bing Chen; Li-Na Meng
Journal:  World J Gastroenterol       Date:  2013-08-21       Impact factor: 5.742

7.  The Alternative NF-κB Pathway in Regulatory T Cell Homeostasis and Suppressive Function.

Authors:  Yenkel Grinberg-Bleyer; Rachel Caron; John J Seeley; Nilushi S De Silva; Christian W Schindler; Matthew S Hayden; Ulf Klein; Sankar Ghosh
Journal:  J Immunol       Date:  2018-02-19       Impact factor: 5.422

8.  Combined immune deficiency in a patient with a novel NFKB2 mutation.

Authors:  Andrew W Lindsley; Yaping Qian; C Alexander Valencia; Kara Shah; Kejian Zhang; Amal Assa'ad
Journal:  J Clin Immunol       Date:  2014-09-10       Impact factor: 8.317

9.  Novel NFKB2 mutation in early-onset CVID.

Authors:  Yiwen Liu; Steven Hanson; Padmalal Gurugama; Alison Jones; Barnaby Clark; Mohammad A A Ibrahim
Journal:  J Clin Immunol       Date:  2014-06-03       Impact factor: 8.317

10.  c-IAP1 and c-IAP2 redundancy differs between T and B cells.

Authors:  Maria Letizia Giardino Torchia; Dietrich B Conze; Jonathan D Ashwell
Journal:  PLoS One       Date:  2013-06-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.